Skip to search.
 TSX Down 0.94% TSX Ventures Down 3.46%

Generex Biotechnology Corp. (GNBT)

-Other OTC
0.01 Down 0.00(5.71%) Aug 24, 1:50PM EDT
|Pre-Market : NaN
Prev Close:0.01
Open:0.01
Bid:N/A
Ask:N/A
1y Target Est:6.00
Beta:-1.41392
Next Earnings Date:N/A
Day's Range:0.01 - 0.01
52wk Range:0.01 - 0.03
Volume:91,043
Avg Vol (3m):1,722,060
Market Cap:5.96M
P/E (ttm):N/A
EPS (ttm):-0.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
GNBTDown 5.71%5.96M
NVODown 1.12%118.90B
MNKDDown 5.43%415.90M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Generex Biotechnology Corporation, a development stage company, researches, develops, and commercializes drug delivery systems and technologies for metabolic and immunological diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback